UBS ASSET MANAGEMENT AMERICAS LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q1 2022$218,863,000
-4.4%
7,3370.0%0.00%
Q3 2021$228,914,000
-11.3%
7,3370.0%0.00%
Q2 2021$258,115,000
+18.1%
7,337
+18.3%
0.00%
Q1 2021$218,550,000
-13.0%
6,200
-7.5%
0.00%
Q4 2020$251,317,0006,7000.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders